Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 43.82
-1.25 (-2.77%)
Jun 2, 2026, 3:00 PM CST
SHA:603334 Market Cap
SHA:603334 has a market cap or net worth of 6.29 billion as of June 2, 2026.
Market Cap
6.29B
Enterprise Value
5.62B
Revenue
3.61B
Ranking
n/a
PE Ratio
37.20
Stock Price
43.82
Market Cap Chart
Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 6.29B, a decrease of -34.36%. That is a compound annual growth rate of -52.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 6.47B | 7.82% |
| Dec 31, 2025 | 6.00B | -37.39% |
| Nov 5, 2025 | 9.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 6.78B |
| Xiangxue Pharmaceutical | 6.56B |
| Jiangsu Aidea Pharmaceutical Group | 6.53B |
| Chengdu Kanghua Biological Products | 6.20B |
| Wuhan Keqian Biology Co.,Ltd | 6.10B |
| Shanghai OPM Biosciences | 6.07B |
| Anhui Huaheng Biotechnology | 5.85B |
| Novogene | 5.73B |